Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.34 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8091775 | 0.95 | USP2 (0.44) | USP2HTTLMNACYP3A4CYP1A2 | |
| SCHEMBL8078612 | 0.95 | USP2 (0.44) | USP2HTTLMNACYP3A4CYP1A2 | |
| SCHEMBL1202052 | 0.84 | CYP3A4 (0.50) | USP2HTTLMNACYP3A4L3MBTL1 | |
| SCHEMBL172427 | 0.84 | USP2 (0.58) | USP2HTTLMNACYP3A4CYP1A2 | |
| SCHEMBL101110 | 0.83 | LMNA (0.46) | LMNACYP3A4L3MBTL1ALDH1A1 | |
| SCHEMBL14894028 | 0.83 | USP2 (0.56) | USP2HTTLMNACYP3A4CYP1A2 | |
| SCHEMBL18327082 | 0.81 | LMNA (0.50) | USP2LMNACYP3A4GPR84L3MBTL1 | |
| SCHEMBL14957670 | 0.81 | LMNA (0.50) | USP2LMNACYP3A4GPR84L3MBTL1 | |
| SCHEMBL20253213 | 0.81 | LMNA (0.50) | USP2LMNACYP3A4GPR84L3MBTL1 | |
| SCHEMBL3360823 | 0.81 | USP2 (0.41) | USP2HTTCYP3A4CYP1A2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1896420-B1 | PROCESS OF PRODUCING BLEACH BOOSTERS | BASF SE (DE) | 2017-01-18 | — | — | EP | disclosed |
| US-20140288309-A1 | PROCESS OF PRODUCING BLEACH BOOSTERS | BASF SE (DE) | 2014-09-25 | — | — | US | disclosed |
| EP-1549631-B1 | Alkyl glycidol carbonates as co-surfactants | BASF SE (DE) | 2014-01-08 | — | — | EP | disclosed |
| EP-1891195-B1 | ORGANIC CATALYST WITH ENHANCED ENZYME COMPATIBILITY | PROCTER & GAMBLE (US) | 2012-10-17 | — | — | EP | disclosed |
| US-8147563-B2 | Organic catalyst with enhanced enzyme compatibility | THE PROCTER & GAMBLE COMPANY (US) | 2012-04-03 | — | — | US | disclosed |
| EP-1599435-B1 | REACTION PRODUCTS OF 2-PROPYLHEPTANOL WITH 1-HALOGEN-2,3-EPOXYPROPANES AND 1-HYDROXY-2,3-EPOXYPROPANE | BASF SE (DE) | 2012-03-07 | — | — | EP | disclosed |
| US-20110283463-A1 | ORGANIC CATALYST WITH ENHANCED ENZYME COMPATIBILITY | THE PROCTER & GAMBLE COMPANY (US) | 2011-11-24 | — | — | US | disclosed |
| US-8021437-B2 | Organic catalyst with enhanced enzyme compatiblity | THE PROCTER & GAMBLE COMPANY (US) | 2011-09-20 | — | — | US | disclosed |
| US-20100223737-A1 | ORGANIC CATALYST WITH ENHANCED ENZYME COMPATIBLITY | PROCTER & GAMBLE COMPANY, THE | 2010-09-09 | — | — | US | disclosed |
| US-7666903-B2 | Reaction products of 2-propylheptanol with 1-halogen-2,3-epoxypropanes and 1-hydroxy-2,3-epoxypropane | BASF AKTIENGESELLSCHAFT (DE) | 2010-02-23 | — | — | US | disclosed |
| WO-2009060421-A2 | ORGANIC CATALYST WITH ENHANCED ENZYME COMPATIBLITY | THE PROCTER & GAMBLE COMPANY (US) | 2009-05-14 | — | — | WO | disclosed |
| US-20080274879-A1 | Process of producing an organic catalyst | HILER GEORGE DOUGLAS | 2008-11-06 | — | — | US | disclosed |
| US-20080200682-A1 | Process of Producing Bleach Boosters | BASF AKTIENGESELLSCHAFT (DE) | 2008-08-21 | — | — | US | disclosed |
| EP-1891195-A1 | ORGANIC CATALYST WITH ENHANCED ENZYME COMPATIBILITY | The Procter and Gamble Company (US) | 2008-02-27 | — | — | EP | disclosed |
| US-20070197417-A1 | Organic catalyst with enhanced enzyme compatiblity | PROCTER & GAMBLE COMPANY, THE | 2007-08-23 | — | — | US | disclosed |
| WO-2007001262-A1 | ORGANIC CATALYST WITH ENHANCED ENZYME COMPATIBILITY | THE PROCTER & GAMBLE COMPANY (US) | 2007-01-04 | — | — | WO | disclosed |
| EP-1680404-A1 | PROCESS FOR PRODUCING DIHYDROISOQUINOLINE ZWITTERIONS | The Procter & Gamble Company (US) | 2006-07-19 | — | — | EP | disclosed |
| US-20060089284-A1 | Organic catalyst with enhanced enzyme compatibility | PROCTER & GAMBLE COMPANY, THE | 2006-04-27 | — | — | US | disclosed |
| US-20050113246-A1 | Process of producing an organic catalyst | THE PROCTER & GAMBLE COMPANY | 2005-05-26 | — | — | US | disclosed |
| WO-2005047264-A1 | PROCESS FOR PRODUCING DIHYDROISOQUINOLINE ZWITTERIONS | THE PROCTER & GAMBLE COMPANY (US) | 2005-05-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080200682-A1 | Process of Producing Bleach Boosters | SQLE, BCHE, CAT | USP2 1512/4885HTT 383/4885LMNA 3583/4885 |
| US-20140288309-A1 | PROCESS OF PRODUCING BLEACH BOOSTERS | SQLE, BCHE, CAT | USP2 1512/4885HTT 383/4885LMNA 3583/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.